GlassScriptPhysician profile
Ashley M Ono
NPI 1720245400
$1,859.62
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $34.61 · 2021: $630 · 2022: $1,116 · 2023: $47.29 · 2024: $31.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $78.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $78.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $774.20 | 2021-2022 | |
| Amarin Pharma, INC. | $167.57 | 2022 | |
| Novo Nordisk INC | $165.01 | 2022 | |
| Abbvie INC. | $163.90 | 2022-2024 | |
| Glaxosmithkline, LLC. | $136.65 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $128.78 | 2022 | |
| Lilly USA, LLC | $95.38 | 2022 | |
| Novartis Pharmaceuticals Corporation | $71.32 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $42.50 | 2022 | |
| Amgen INC. | $42.36 | 2022 | |
| Gilead Sciences, INC. | $34.61 | 2020 | |
| Esperion Therapeutics, INC. | $19.73 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Ono listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.